Sarcopenia
Conditions
Interventions
Observation group:none
Sponsors
General Hospital of the Western Theater of the Chinese People's Liberation Army
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age>= 65 years; 2. Stable underlying disease; 3. All patients received and were able to cooperate with dual-energy X-ray body composition analysis test, grip strength test and hematology test; 4. Informed consent of the patient;
Exclusion criteria
Exclusion criteria: 1. Acute infectious phase; 2. Inability to communicate normally; 3. Missing data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nuclear factor erythroid 2;NAD(P)H:quinone acceptor oxidoreductase 1;Heme Oxygenase 1;Human Soluble Receptor for Advanced Glycation End-products ;3-Methylhistidine;Type III Procollagen N-Terminal Propeptide;lrisin;Myostatin;Human Growth Differentiation Factor 15 ;Human Macrophage Migration Inhibitory Factor;Leptin;Human Insulin-like Growth Factor 1; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index;Grip; | — |
Countries
China
Contacts
Public ContactWang Zhang
General Hospital of the Western Theater of the Chinese People's Liberation Army
Outcome results
None listed